Steps forward in the treatment of IgA nephropathy
Crossref DOI link: https://doi.org/10.1038/s41581-024-00925-y
Published Online: 2024-12-18
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Coppo, Rosanna
Text and Data Mining valid from 2024-12-18
Version of Record valid from 2024-12-18
Article History
First Online: 18 December 2024
Competing interests
: R.C. has served as a consultant on advisory boards and/or steering committees for Chinook, Novartis, Otsuka, STADApharm and Travere.